Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Vivmark Residential (VMRK)

Equity Residential Q4 EPS falls 9.1% to $1.00; 2026 normalized FFO guided to $4.02-$4.14

Mixed Impact 3 of 5 earnings Written later

Equity Residential reported fourth-quarter 2025 diluted EPS of $1.00, down from $1.10, while normalized FFO per share rose to $1.03 from $1.00 and full-year 2025 EPS rose to $2.94 from $2.72. The company guided 2026 normalized FFO per share to $4.02 to $4.14, but 2026 EPS guidance of $1.44 to $1.56 implies a 49.0% decline at the midpoint versus 2025. The filing names Equity Residential (NYSE: EQR), not VIVMARK RESIDENTIAL (VMRK) as stated in the request; the summary reflects the filing.

Key points

  • Q4 2025 diluted EPS was $1.00 versus $1.10 a year earlier; normalized FFO per share was $1.03 versus $1.00.
  • Full-year 2025 diluted EPS was $2.94 versus $2.72; normalized FFO per share was $3.99 versus $3.89.
  • 2026 guidance: EPS $1.44 to $1.56 (midpoint down 49.0% versus 2025); normalized FFO $4.02 to $4.14 (midpoint up 2.3%).
  • During 2025 the company repurchased about 4.8 million common shares for about $300.0 million.

The filing

CompanyVivmark Residential (VMRK)
Form8-K, current report
Filed with the SECFeb 5, 2026, 4:22 PM ET
Accession number0001193125-26-039455

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:10 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 05, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.